MyVisionTest News Archive

Displaying news items tagged with FDA (More tags »)
SELECT PAGE
First <<  1   >> Last

Eylea
Jan 8, 2012
The US Food and Drug Administration (FDA) approved aflibercept ophthalmic solution (Eylea, Regeneron Pharmaceuticals Inc) for the treatment of neovascular ("wet") age-related macular degeneration (AMD) in November 2011. "Eylea is an important new treatment option for adults with wet AMD," said Edward Cox of the FDA. "It is a potentially...

Full Article


The Iluvien insert, shown on a human finger to indicate size
Sep 20, 2010
The U.S. Food and Drug Administration has granted priority review status to Alimera Sciences' new drug application for its Iluvien intravitreal insert, the company announced in a press release. With the priority review status, which accelerates the FDA's standard review time from 10 months to 6 months, Alimera could receive a response for the...

Full Article


Lucentis
Jun 27, 2010
Following a 6-month priority review, the U.S. Food and Drug Administration has approved Lucentis (ranibizumab) for treatment of macular edema due to retinal vein occlusion, Genentech announced in a press release. "This approval provides an important new medicine for people experiencing the unexpected vision loss associated with macular edema...

Full Article


Avastin
Jan 16, 2009
The Food and Drug Administration (FDA) has finalized guidelines that will allow pharmaceutical and device company reps to distribute journal articles to doctors about off-label uses of their products. The new recommendations are a finalized version of the draft about "good reprint practices" first issued in February 2008. Avastin, while not...

Full Article

Tags: Avastin, FDA

Apr 11, 2008
Embryonic stem cells that may cure diseases also carry new risks, from the danger improper cells will be implanted to the prospect they may travel to the wrong parts of the body, companies told U.S. advisers April 10th. Geron Corp., Novocell Inc. and Advanced Cell Technology Inc. appeared before a Food and Drug Administration advisory panel...

Full Article


Apr 8, 2008
Embryonic stem cells may someday cure disease, reverse paralysis or restore memory. Scientists worry they also may trigger benign tumors, and even cancer. Geron Corp. and Advanced Cell Technology Inc. plan this year to begin the first human tests of therapies created with stem cells extracted from human embryos. The U.S. Food and Drug...

Full Article


SELECT PAGE
First <<  1   >> Last
Most Popular
Less - past - More